This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

LIQUENT, EXTEDO And Lorenz Add Critical Publishing Capabilities To Industry's First Cloud-Based Application For Managing Submissions Content

"Veeva is applying technologies that will shape the future of application delivery," said Raoul Lorenz, Chief Executive Officer, LORENZ Life Sciences Group. "LORENZ is investing resources to understand further collaboration opportunities, as well as the applicability of Veeva technologies to our customer base."

LIQUENT, with more than 200 biopharmaceutical and life sciences clients worldwide, is a leading provider of software and professional services that support the regulatory business processes of global life sciences companies. Rick Riegel, Corporate Vice President of LIQUENT, a PAREXEL company, concluded, "Together with Veeva, we're providing an end-to-end solution for managing and publishing regulatory submissions in the cloud. When done right, cloud computing creates a true competitive advantage."

Also announced at DIA 2013 today, Veeva launched its cloud-based Vault Investigator Portal. Visit the company's booth # 1557 for demonstrations of Vault Submissions and the new LIQUENT integration as well as the company's new Vault Investigator Portal.

About Vault Development Suite

Veeva Vault Submissions is part of the Veeva Development Suite, the only cloud-based suite of integrated content management applications for the life sciences industry. Spanning every major part of a life sciences company - from R&D to clinical trials, to quality and manufacturing - the Veeva Development Suite gives pharmaceutical, biotechnology and medical device companies the ability to deploy a single content management system globally. All Development Suite applications offer real-time reporting and dashboards, an intuitive web interface, and a true multitenant cloud architecture that continuously delivers rapid innovation.

About Veeva Systems

Veeva Systems is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence and customer success, Veeva has over 150 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Founded in 2007, Veeva is a privately held company headquartered in the San Francisco Bay Area, with offices in Philadelphia, Barcelona, Budapest, London, Paris, Beijing, Shanghai and Tokyo. For more information, visit http://www.veeva.com.

Copyright (c) 2013 Veeva Systems. All rights reserved. Veeva and the Veeva logo are registered trademarks of Veeva Systems. Veeva Systems owns other registered and unregistered trademarks. Other names used herein may be trademarks of their respective owners.

2 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,051.24 +72.11 0.42%
S&P 500 1,991.33 +4.82 0.24%
NASDAQ 4,527.4170 +0.9350 0.02%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs